• Something wrong with this record ?

GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction

S. Littnerova, P. Kala, J. Jarkovsky, L. Kubkova, K. Prymusova, P. Kubena, M. Tesak, O. Toman, M. Poloczek, J. Spinar, L. Dusek, J. Parenica,

. 2015 ; 10 (4) : e0123215. [pub] 20150420

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc16010300

AIM: To compare the prognostic accuracy of six scoring models for up to three-year mortality and rates of hospitalisation due to acute decompensated heart failure (ADHF) in STEMI patients. METHODS AND RESULTS: A total of 593 patients treated with primary PCI were evaluated. Prospective follow-up of patients was ≥3 years. Thirty-day, one-year, two-year, and three-year mortality rates were 4.0%, 7.3%, 8.9%, and 10.6%, respectively. Six risk scores--the TIMI score and derived dynamic TIMI, CADILLAC, PAMI, Zwolle, and GRACE--showed a high predictive accuracy for six- and 12-month mortality with area under the receiver operating characteristic curve (AUC) values of 0.73-0.85. The best predictive values for long-term mortality were obtained by GRACE. The next best-performing scores were CADILLAC, Zwolle, and Dynamic TIMI. All risk scores had a lower prediction accuracy for repeat hospitalisation due to ADHF, except Zwolle with the discriminatory capacity for hospitalisation up to two years (AUC, 0.80-0.83). CONCLUSIONS: All tested models showed a high predictive value for the estimation of one-year mortality, but GRACE appears to be the most suitable for the prediction for a longer follow-up period. The tested models exhibited an ability to predict the risk of ADHF, especially the Zwolle model.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010300
003      
CZ-PrNML
005      
20201106135506.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0123215 $2 doi
024    7_
$a 10.1371/journal.pone.0123215 $2 doi
035    __
$a (PubMed)25893501
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Littnerova, Simona $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
245    10
$a GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction / $c S. Littnerova, P. Kala, J. Jarkovsky, L. Kubkova, K. Prymusova, P. Kubena, M. Tesak, O. Toman, M. Poloczek, J. Spinar, L. Dusek, J. Parenica,
520    9_
$a AIM: To compare the prognostic accuracy of six scoring models for up to three-year mortality and rates of hospitalisation due to acute decompensated heart failure (ADHF) in STEMI patients. METHODS AND RESULTS: A total of 593 patients treated with primary PCI were evaluated. Prospective follow-up of patients was ≥3 years. Thirty-day, one-year, two-year, and three-year mortality rates were 4.0%, 7.3%, 8.9%, and 10.6%, respectively. Six risk scores--the TIMI score and derived dynamic TIMI, CADILLAC, PAMI, Zwolle, and GRACE--showed a high predictive accuracy for six- and 12-month mortality with area under the receiver operating characteristic curve (AUC) values of 0.73-0.85. The best predictive values for long-term mortality were obtained by GRACE. The next best-performing scores were CADILLAC, Zwolle, and Dynamic TIMI. All risk scores had a lower prediction accuracy for repeat hospitalisation due to ADHF, except Zwolle with the discriminatory capacity for hospitalisation up to two years (AUC, 0.80-0.83). CONCLUSIONS: All tested models showed a high predictive value for the estimation of one-year mortality, but GRACE appears to be the most suitable for the prediction for a longer follow-up period. The tested models exhibited an ability to predict the risk of ADHF, especially the Zwolle model.
650    _2
$a senioři $7 D000368
650    _2
$a plocha pod křivkou $7 D019540
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a srdeční selhání $x diagnóza $7 D006333
650    _2
$a hospitalizace $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a biologické modely $7 D008954
650    _2
$a multivariační analýza $7 D015999
650    _2
$a infarkt myokardu $x mortalita $x ultrasonografie $7 D009203
650    _2
$a propuštění pacienta $7 D010351
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a rizikové faktory $7 D012307
650    _2
$a časové faktory $7 D013997
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kala, Petr $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Jarkovsky, Jiri $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Kubkova, Lenka $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center-Department of Cardiovascular Disease, St Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Kluz, Krystyna $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Hospital Podlesi A.S., Trinec, Czech Republic. $7 xx0243485
700    1_
$a Kubena, Petr $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Tesak, Martin $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Hospital Trebic, Trebic, Czech Republic.
700    1_
$a Toman, Ondrej $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; International Clinical Research Center-Department of Cardiovascular Disease, St Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Poloczek, Martin $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Spinar, Jindrich $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center-Department of Cardiovascular Disease, St Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Dusek, Ladislav $u Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
700    1_
$a Parenica, Jiri $u Department of Cardiology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic; International Clinical Research Center-Department of Cardiovascular Disease, St Anne's University Hospital, Brno, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 4 (2015), s. e0123215
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25893501 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20201106135503 $b ABA008
999    __
$a ok $b bmc $g 1113729 $s 934668
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 10 $c 4 $d e0123215 $e 20150420 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20160408

Find record

Citation metrics

Archiving options